Nanoparticles in Biotechnology and Pharmaceuticals Market

Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules
The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.
In 2020, the market size of Nanoparticles in Biotechnology and Pharmaceuticals is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2020; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2019 has been considered as the base year and 2020 to 2025 as the forecast period to estimate the market size for Nanoparticles in Biotechnology and Pharmaceuticals.

This report studies the global market size of Nanoparticles in Biotechnology and Pharmaceuticals, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nanoparticles in Biotechnology and Pharmaceuticals production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2020, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2020.

In global market, the following companies are covered:
Roche
GE Healthcare
Merck
Novartis
AMAG Pharmaceuticals
Amgen
Bausch & Lomb
Biogen
Celgene
Gilead
Ipsen
Leadiant Biosciences
nanoComposix
Pacira Pharmaceuticals
Pfizer
Shire

Market Segment by Product Type
Fullerenes
Liquid Crystals
Liposomes
Nanoshells
Quantum dots
Superparamagnetic nanoparticles

Market Segment by Application
Biotechnology
Pharmaceutical

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Nanoparticles in Biotechnology and Pharmaceuticals status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nanoparticles in Biotechnology and Pharmaceuticals manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Nanoparticles in Biotechnology and Pharmaceuticals are as follows:
History Year: 2014-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2025